These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10923395)

  • 21. Nitric oxide versus prostaglandin E1 for reduction of pulmonary hypertension in heart transplant candidates.
    Radovancevic B; Vrtovec B; Thomas CD; Croitoru M; Myers TJ; Radovancevic R; Khan T; Massin EK; Frazier OH
    J Heart Lung Transplant; 2005 Jun; 24(6):690-5. PubMed ID: 15949728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitric oxide in the management of pulmonary hypertension in the context of cardiac surgery in the adult.
    Timóteo AT; Abecassis M; Baptista P; Rebocho MJ; Queiroz e Melo J
    Rev Port Cardiol; 2003 Dec; 22(12):1503-11. PubMed ID: 15008066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacological aspects within the scope of pulmonary hypertension].
    Kraupp O
    Med Welt; 1972 Jul; 23(29):1006-8. PubMed ID: 5077680
    [No Abstract]   [Full Text] [Related]  

  • 24. Severe hypoxemia and pulmonary hypertension during orthotopic liver transplantation: a successful use of inhaled nitric oxide.
    Girardis M; Pasqualotto A; Colò F; Dal Pos L; Sabbadini D; Pasqualucci A; Pasetto A
    Intensive Care Med; 1999 Jun; 25(6):638. PubMed ID: 10416922
    [No Abstract]   [Full Text] [Related]  

  • 25. Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension.
    Ghofrani HA; Pepke-Zaba J; Barbera JA; Channick R; Keogh AM; Gomez-Sanchez MA; Kneussl M; Grimminger F
    J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):68S-72S. PubMed ID: 15194181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of Persistent Pulmonary Hypertension of the Newborn (PPHN) is in its infancy.
    Kissoon N
    J Crit Care; 2006 Jun; 21(2):223. PubMed ID: 16769472
    [No Abstract]   [Full Text] [Related]  

  • 27. EDRF/nitric oxide. The endogenous nitrovasodilator and a new cellular messenger.
    Johns RA
    Anesthesiology; 1991 Dec; 75(6):927-31. PubMed ID: 1741512
    [No Abstract]   [Full Text] [Related]  

  • 28. Citrulline, Viagra and BiDil--bad medicine.
    Czp A
    Altern Med Rev; 2005 Dec; 10(4):265-7. PubMed ID: 16400750
    [No Abstract]   [Full Text] [Related]  

  • 29. [Nitric oxide and hypertension. Therapeutic perspectives].
    Rossi G
    Recenti Prog Med; 2001 Oct; 92(10):578-9. PubMed ID: 11695300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prospects in the treatment of pulmonary hypertension with nitric oxide].
    Yu R
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Apr; 21(4):195. PubMed ID: 11326961
    [No Abstract]   [Full Text] [Related]  

  • 31. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.
    Preston IR; Klinger JR; Houtches J; Nelson D; Farber HW; Hill NS
    Respir Med; 2005 Dec; 99(12):1501-10. PubMed ID: 15890512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination therapy for pulmonary hypertension: a glimpse into the future?
    Channick RN; Rubin LJ
    Crit Care Med; 2000 Mar; 28(3):896-7. PubMed ID: 10752856
    [No Abstract]   [Full Text] [Related]  

  • 33. [Inhaled vasodilators].
    Zwissler B
    Anaesthesist; 2002 Aug; 51(8):603-24. PubMed ID: 12391520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Status report: inhaled nitric oxide in persistent pulmonary hypertension/hypoxic respiratory failure of neonate.
    Cook LN
    Przegl Lek; 2002; 59 Suppl 1():10-3. PubMed ID: 12108054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy.
    Ozkan M; Dweik RA; Laskowski D; Arroliga AC; Erzurum SC
    Lung; 2001; 179(4):233-43. PubMed ID: 11891614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison between two drugs on the hemodynamic evaluation of pulmonary hypertension prior to heart transplantation.
    Mogollón Jiménez MV; Escoresca Ortega AM; Hinojosa Pérez R; Lage Gallé E; Herruzo Avilés A; Sobrino Márquez M; Frutos López M; Romero Rodríguez N; Pérez de la Yglesia R; Martínez Martínez A
    Transplant Proc; 2008 Nov; 40(9):3009-11. PubMed ID: 19010174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary hypertension: inhaled nitric oxide, sildenafil and natriuretic peptides.
    Steiner MK; Preston IR; Klinger JR; Hill NS
    Curr Opin Pharmacol; 2005 Jun; 5(3):245-50. PubMed ID: 15907910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement.
    Fattouch K; Sbraga F; Bianco G; Speziale G; Gucciardo M; Sampognaro R; Ruvolo G
    J Card Surg; 2005; 20(2):171-6. PubMed ID: 15725144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does inhaled nitric oxide improve survival in operated congenital disease with severe pulmonary hypertension?
    Sharma R; Raizada N; Choudhary SK; Bhan A; Kumar P; Juneja R; Kothari SS; Saxena A; Venugopal P
    Indian Heart J; 2001; 53(1):48-55. PubMed ID: 11456141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iloprost as 'rescue' therapy for pulmonary hypertension of the neonate.
    De Luca D; Zecca E; Piastra M; Romagnoli C
    Paediatr Anaesth; 2007 Apr; 17(4):394-5. PubMed ID: 17359413
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.